Study: Omicron evades some but not all monoclonal antibodies
Soaring COVID self-test kit sales fuel India underreporting fears
21 January 2022New high-throughput method greatly expands view of how mutations impact cells
21 January 2022Study: Omicron evades some but not all monoclonal antibodies
Several, but not all, of the human monoclonal antibodies used clinically to prevent patients from becoming severely ill from COVID-19 may not be protective against the omicron variant now sweeping across the United States, researchers reported Jan. 19 in the journal Nature Medicine.
